| Phase 4 |
| NCT06543082 |
MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study |
Acute Coronary Syndrome |
Recruiting |
2026-02-18 |
| NCT06815042 |
The Analysis of Efficacy Factors for Autologous Platelet-Rich Plasma Therapy in the… |
Elbow Tendinopathy |
Not Yet Recruiting |
2025-02-07 |
| Phase 2 |
| NCT07493668 |
Fostrox Plus Lenvatinib vs Lenvatinib in Advanced Hepatocellular Carcinoma After… |
Hepatocellular Carcinoma (HCC) |
Recruiting |
2026-05-22 |
| NCT07774247 |
Atezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular Carcinoma |
Hepatocellular Carcinoma (HCC) |
Not Yet Recruiting |
2026-08-19 |
| Phase 1 |
| NCT07143812 |
A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients… |
Glioblastoma (GBM) |
Recruiting |
2026-01-22 |
| Not applicable |
| NCT07027891 |
The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram… |
Myocardial Infarction (MI) |
Recruiting |
2026-07-28 |
| NCT06985693 |
Medipixel XA-Assisted PCI in Coronary Artery Disease |
Percutaneous Coronary Intervention (PCI) |
Recruiting |
2025-05-22 |
| NCT05421650 |
Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer… |
Cervical Cancer |
Recruiting |
2025-04-09 |
| Not specified |
| NCT06648057 |
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With… |
Biliary Tract Cancer |
Recruiting |
2026-03-18 |
| NCT07142226 |
Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC |
Biliary Tract Cancer |
Recruiting |
2026-03-18 |
| NCT07151118 |
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer |
Biliary Tract Cancer |
Recruiting |
2026-03-18 |
| NCT06893380 |
Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer |
Locally Advanced Biliary Tract Cancers |
Recruiting |
2025-09-15 |
| NCT07830628 |
Bile ctDNA Genomic Profiling and Concordance With Tumor Tissue in Biliary Tract Cancer |
Biliary Tract Cancer (BTC) |
Not Yet Recruiting |
2026-10-13 |
| NCT06619353 |
RCVR (Residual CardioVascular Risk) Prospective Study |
Coronary Artery Disease |
Active, Not Recruiting |
2026-02-18 |